Yahav Achim Ve Achayot - Provident Funds Management Company’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,720
Closed -$774K 59
2023
Q1
$774K Hold
9,720
0.76% 47
2022
Q4
$659K Sell
9,720
-18,200
-65% -$1.07M 0.62% 47
2022
Q3
$1.4M Hold
27,920
1.36% 22
2022
Q2
$1.54M Hold
27,920
1.38% 21
2022
Q1
$1.55M Hold
27,920
1.19% 29
2021
Q4
$1.56M Hold
27,920
1.12% 31
2021
Q3
$1.34M Buy
+27,920
New +$1.35M 1.05% 36

Other funds holding NVO

Yahav Achim Ve Achayot - Provident Funds Management Company's NVO Position: Q2 2023 in Review

Yahav Achim Ve Achayot - Provident Funds Management Company sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 9,720 shares — an estimated $774K sold.

Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in NVO in Q3 2021 and held it in 7 quarters. The position peaked at $1.56M in Q4 2021. 1,198 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • Yahav Achim Ve Achayot - Provident Funds Management Company reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
  • Yahav Achim Ve Achayot - Provident Funds Management Company sold 9,720 Novo Nordisk shares in Q2 2023, an estimated $774K.
  • Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in Novo Nordisk in Q3 2021 and held it in 7 quarters.
  • Yahav Achim Ve Achayot - Provident Funds Management Company's Novo Nordisk position peaked at $1.56M in Q4 2021.
  • 1,198 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Yahav Achim Ve Achayot - Provident Funds Management Company's 13F filing for Q2 2023, filed 14 Aug 2023.